• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

这种突变意味着什么?淋巴恶性肿瘤中变异解读的工具和陷阱。

What Does This Mutation Mean? The Tools and Pitfalls of Variant Interpretation in Lymphoid Malignancies.

机构信息

Centre Léon Bérard, Service d'Hématologie Clinique, 69008 Lyon, France.

Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Laboratoire de Biochimie et Biologie moléculaire, 69495 Pierre-Bénite CEDEX, France.

出版信息

Int J Mol Sci. 2018 Apr 20;19(4):1251. doi: 10.3390/ijms19041251.

DOI:10.3390/ijms19041251
PMID:29677173
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5979354/
Abstract

High throughput sequencing (HTS) is increasingly important in determining cancer diagnoses, with subsequent prognostic and therapeutic implications. The biology of cancer is becoming increasingly deciphered and it is clear that therapy needs to be individually tailored. Whilst translational research plays an important role in lymphoid malignancies, few guidelines exist to guide biologists and routine laboratories through this constantly evolving field. In this article, we review the challenges of interpreting HTS in lymphoid malignancies and provide a toolkit to interpret single nucleotide variants obtained from HTS. We define the pre-analytical issues such as sequencing DNA obtained from formalin-fixed and paraffin-embedded tissue (FFPE), the acquisition of germline DNA, or the bioinformatic pitfalls, the analytical issues encountered and how to manage them. We describe the main constitutional and cancer databases, their characteristics and limitations, with an emphasis on variant interpretation in lymphoid malignancies. Finally, we discuss the challenges of predictions that one can make using in silico or in vitro modelling, pharmacogenomic screening, and the limits of those prediction tools. This description of the current status in genomic interpretation highlights the need for new large databases and international collaboration in the lymphoma field.

摘要

高通量测序(HTS)在确定癌症诊断方面变得越来越重要,具有后续的预后和治疗意义。癌症的生物学正在被越来越多地破译,很明显,治疗需要个体化。虽然转化研究在淋巴恶性肿瘤中发挥着重要作用,但几乎没有指南可以指导生物学家和常规实验室在这个不断发展的领域中前进。在本文中,我们回顾了在解读淋巴恶性肿瘤中的 HTS 时所面临的挑战,并提供了一套工具来解读从 HTS 获得的单核苷酸变异。我们定义了一些分析前的问题,如从福尔马林固定和石蜡包埋组织(FFPE)中获得的测序 DNA,获取胚系 DNA,或生物信息学陷阱,以及分析中遇到的问题和如何管理这些问题。我们描述了主要的遗传性和癌症数据库,及其特征和局限性,重点是在淋巴恶性肿瘤中的变异解读。最后,我们讨论了使用计算机或体外模型进行预测、药物基因组学筛查以及这些预测工具的局限性所带来的挑战。对基因组解读现状的描述突出了淋巴瘤领域需要新的大型数据库和国际合作。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b522/5979354/a9696b67db69/ijms-19-01251-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b522/5979354/a9696b67db69/ijms-19-01251-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b522/5979354/a9696b67db69/ijms-19-01251-g001.jpg

相似文献

1
What Does This Mutation Mean? The Tools and Pitfalls of Variant Interpretation in Lymphoid Malignancies.这种突变意味着什么?淋巴恶性肿瘤中变异解读的工具和陷阱。
Int J Mol Sci. 2018 Apr 20;19(4):1251. doi: 10.3390/ijms19041251.
2
Somatic Mutation Screening Using Archival Formalin-Fixed, Paraffin-Embedded Tissues by Fluidigm Multiplex PCR and Illumina Sequencing.使用Fluidigm多重PCR和Illumina测序对福尔马林固定、石蜡包埋存档组织进行体细胞突变筛查
J Mol Diagn. 2015 Sep;17(5):521-32. doi: 10.1016/j.jmoldx.2015.04.008. Epub 2015 Jul 9.
3
HaloPlex Targeted Resequencing for Mutation Detection in Clinical Formalin-Fixed, Paraffin-Embedded Tumor Samples.用于临床福尔马林固定、石蜡包埋肿瘤样本中突变检测的HaloPlex靶向重测序
J Mol Diagn. 2015 Nov;17(6):729-39. doi: 10.1016/j.jmoldx.2015.06.009. Epub 2015 Sep 3.
4
Whole exome sequencing (WES) on formalin-fixed, paraffin-embedded (FFPE) tumor tissue in gastrointestinal stromal tumors (GIST).对胃肠道间质瘤(GIST)的福尔马林固定、石蜡包埋(FFPE)肿瘤组织进行全外显子组测序(WES)。
BMC Genomics. 2015 Nov 3;16:892. doi: 10.1186/s12864-015-1982-6.
5
A computational tool to detect DNA alterations tailored to formalin-fixed paraffin-embedded samples in cancer clinical sequencing.一种针对癌症临床测序中福尔马林固定石蜡包埋样本的 DNA 改变的计算工具。
Genome Med. 2018 Jun 7;10(1):44. doi: 10.1186/s13073-018-0547-0.
6
Targeted or whole genome sequencing of formalin fixed tissue samples: potential applications in cancer genomics.福尔马林固定组织样本的靶向或全基因组测序:在癌症基因组学中的潜在应用
Oncotarget. 2015 Sep 22;6(28):25943-61. doi: 10.18632/oncotarget.4671.
7
Clinical Validation of a Targeted Next-Generation Sequencing Panel for Lymphoid Malignancies.淋巴恶性肿瘤靶向二代测序 panel 的临床验证。
J Mol Diagn. 2024 Jul;26(7):583-598. doi: 10.1016/j.jmoldx.2024.03.008. Epub 2024 Apr 4.
8
Next-generation sequencing of formalin-fixed, paraffin-embedded tumor biopsies: navigating the perils of old and new technology to advance cancer diagnosis.福尔马林固定、石蜡包埋肿瘤活检组织的新一代测序:应对新旧技术风险以推动癌症诊断
Expert Rev Mol Diagn. 2013 Nov;13(8):769-72. doi: 10.1586/14737159.2013.845090. Epub 2013 Oct 11.
9
Targeted Next Generation Sequencing as a Reliable Diagnostic Assay for the Detection of Somatic Mutations in Tumours Using Minimal DNA Amounts from Formalin Fixed Paraffin Embedded Material.靶向新一代测序作为一种可靠的诊断检测方法,用于使用来自福尔马林固定石蜡包埋材料的微量DNA检测肿瘤中的体细胞突变。
PLoS One. 2016 Feb 26;11(2):e0149405. doi: 10.1371/journal.pone.0149405. eCollection 2016.
10
Formalin fixation increases deamination mutation signature but should not lead to false positive mutations in clinical practice.福尔马林固定会增加脱氨突变特征,但在临床实践中不应该导致假阳性突变。
PLoS One. 2018 Apr 26;13(4):e0196434. doi: 10.1371/journal.pone.0196434. eCollection 2018.

引用本文的文献

1
Real life evaluation of AlphaMissense predictions in hematological malignancies.血液系统恶性肿瘤中 AlphaMissense 预测的真实生活评估。
Leukemia. 2024 Feb;38(2):420-423. doi: 10.1038/s41375-023-02116-3. Epub 2023 Dec 22.
2
Next-generation sequencing methodologies to detect low-frequency mutations: "Catch me if you can".下一代测序方法检测低频突变:“若能抓住,尽管来抓”。
Mutat Res Rev Mutat Res. 2023 Jul-Dec;792:108471. doi: 10.1016/j.mrrev.2023.108471. Epub 2023 Sep 15.
3
Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA Registry.

本文引用的文献

1
Standards and Guidelines for Validating Next-Generation Sequencing Bioinformatics Pipelines: A Joint Recommendation of the Association for Molecular Pathology and the College of American Pathologists.下一代测序生物信息学管道验证的标准和指南:分子病理学协会和美国病理学家学院的联合建议。
J Mol Diagn. 2018 Jan;20(1):4-27. doi: 10.1016/j.jmoldx.2017.11.003. Epub 2017 Nov 21.
2
Clonality in context: hematopoietic clones in their marrow environment.背景下的克隆性:骨髓环境中的造血克隆
Blood. 2017 Nov 30;130(22):2363-2372. doi: 10.1182/blood-2017-07-794362. Epub 2017 Oct 18.
3
Resources for Interpreting Variants in Precision Genomic Oncology Applications.
2668例成年急性髓系白血病患者的分子图谱及新基因组分类的验证:来自PETHEMA注册研究的真实数据
Cancers (Basel). 2023 Jan 10;15(2):438. doi: 10.3390/cancers15020438.
4
Sequencing of Cutaneous Squamous Cell Carcinoma Primary Tumors and Patient-Matched Metastases Reveals as a Potential Driver in Metastases and Low Mutational Concordance in Immunocompromised Patients.皮肤鳞状细胞癌原发肿瘤及患者匹配转移灶的测序揭示了在免疫功能低下患者转移过程中的潜在驱动因素以及低突变一致性。
JID Innov. 2022 Mar 23;2(4):100122. doi: 10.1016/j.xjidi.2022.100122. eCollection 2022 Jul.
5
The Impact of COVID-19 Pandemic in Portuguese Cancer Patients: A Retrospective Study.《COVID-19 大流行对葡萄牙癌症患者的影响:一项回顾性研究》。
Int J Environ Res Public Health. 2021 Aug 13;18(16):8552. doi: 10.3390/ijerph18168552.
6
Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak.癌症患者似乎更容易感染 SARS-CoV-2:COVID-19 爆发期间的一项多中心研究。
Cancer Discov. 2020 Jun;10(6):783-791. doi: 10.1158/2159-8290.CD-20-0422. Epub 2020 Apr 28.
7
The Need for a Consensus Next-generation Sequencing Panel for Mature Lymphoid Malignancies.成熟淋巴细胞恶性肿瘤下一代测序共识专家组的必要性。
Hemasphere. 2018 Dec 27;3(1):e169. doi: 10.1097/HS9.0000000000000169. eCollection 2019 Feb.
8
Functional Characterization of Glucocorticoid Receptor Variants Is Required to Avoid Misinterpretation of NGS Data.需要对糖皮质激素受体变体进行功能表征以避免对NGS数据的错误解读。
J Endocr Soc. 2019 Mar 6;3(5):865-881. doi: 10.1210/js.2019-00028. eCollection 2019 May 1.
9
Two-way detection of image features and immunolabeling of lymphoma cells with one-step microarray analysis.通过一步式微阵列分析对淋巴瘤细胞进行图像特征双向检测和免疫标记。
Biomicrofluidics. 2018 Dec 28;12(6):064106. doi: 10.1063/1.5063369. eCollection 2018 Nov.
精准基因组肿瘤学应用中变异解读的资源
Front Oncol. 2017 Sep 19;7:214. doi: 10.3389/fonc.2017.00214. eCollection 2017.
4
RareVar: A Framework for Detecting Low-Frequency Single-Nucleotide Variants.RareVar:一种用于检测低频单核苷酸变异的框架。
J Comput Biol. 2017 Jul;24(7):637-646. doi: 10.1089/cmb.2017.0057. Epub 2017 May 25.
5
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.从10000例患者的前瞻性临床测序中揭示的转移性癌症的突变图谱。
Nat Med. 2017 Jun;23(6):703-713. doi: 10.1038/nm.4333. Epub 2017 May 8.
6
Guidelines for Validation of Next-Generation Sequencing-Based Oncology Panels: A Joint Consensus Recommendation of the Association for Molecular Pathology and College of American Pathologists.基于新一代测序的肿瘤学检测板验证指南:分子病理学协会和美国病理学家学会联合共识推荐
J Mol Diagn. 2017 May;19(3):341-365. doi: 10.1016/j.jmoldx.2017.01.011. Epub 2017 Mar 21.
7
Evaluating Variant Calling Tools for Non-Matched Next-Generation Sequencing Data.评估用于非配对下一代测序数据的变异调用工具。
Sci Rep. 2017 Feb 24;7:43169. doi: 10.1038/srep43169.
8
Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists.癌症序列变异解读与报告的标准和指南:分子病理学协会、美国临床肿瘤学会和美国病理学家学会联合共识推荐
J Mol Diagn. 2017 Jan;19(1):4-23. doi: 10.1016/j.jmoldx.2016.10.002.
9
Evaluating the evaluation of cancer driver genes.评估癌症驱动基因的评估。
Proc Natl Acad Sci U S A. 2016 Dec 13;113(50):14330-14335. doi: 10.1073/pnas.1616440113. Epub 2016 Nov 22.
10
OutLyzer: software for extracting low-allele-frequency tumor mutations from sequencing background noise in clinical practice.OutLyzer:用于在临床实践中从测序背景噪声中提取低等位基因频率肿瘤突变的软件。
Oncotarget. 2016 Nov 29;7(48):79485-79493. doi: 10.18632/oncotarget.13103.